...
首页> 外文期刊>Epilepsy research >Clinical aspects and biological bases of drug-resistant epilepsies.
【24h】

Clinical aspects and biological bases of drug-resistant epilepsies.

机译:耐药性癫痫的临床方面和生物学基础。

获取原文
获取原文并翻译 | 示例
           

摘要

The definition of drug-resistant epilepsy (DRE) is elusive and still controversial owing to some unresolved questions such as: how many drugs should be tried before a patient is considered intractable; to which extent side-effects may be acceptable; how many years are necessary before establishing drug resistance. In some cases, the view of epilepsy as a progressive disorder constitutes another important issue. Despite the use of new antiepileptic drugs (AEDs), intractable epilepsy represents about 20-30% of all cases, probably due to the multiple pathogenetic mechanisms underlying refractoriness. Several risk factors for pharmacoresistance are well known, even if the list of clinical features and biological factors currently accepted to be associated with difficult-to-treat epilepsy is presumably incomplete and, perhaps, disputable. For some of these factors, the biological basis may be common, mainly represented by mesial temporal sclerosis or by the presence of focal lesions. In other cases, microdysgenesis or dysplastic cortex, with abnormalities in the morphology and distribution of local-circuit (inhibitory) neurons, may be responsible for the severity of seizures. The possible influence of genes in conditioning inadequate intraparenchimal drug concentration, and the role of some cytokines determining an increase in intracellular calcium levels or an excessive growth of distrophic neurites, constitute other possible mechanisms of resistance. Several hypotheses on the mechanisms involved in the generation of DRE have been indicated: (a) ontogenic abnormalities in brain maturation; (b) epilepsy-induced alterations in network, neuronal, and glial properties in seizure-prone regions such as the hippocampus; (c) kindling phenomenon; (d) reorganization of cortical tissue in response to seizure-induced disturbances in oxygen supply. Such hypotheses need to be confirmed with suitable experimental models of intractable epilepsy that are specifically dedicated, which have until now been lacking.
机译:耐药性癫痫(DRE)的定义尚不清楚,并且由于一些未解决的问题而引起争议,例如:在患者被认为难以治疗之前应尝试多少种药物;在何种程度上可以接受副作用;建立耐药性需要多少年。在某些情况下,将癫痫病视为进行性疾病构成了另一个重要问题。尽管使用了新的抗癫痫药(AED),但顽固性癫痫仍占所有病例的20-30%,这可能是由于难治性的多种致病机制所致。尽管目前公认与难治性癫痫有关的临床特征和生物学因素清单可能不完整,甚至可能引起争议,但药物抗药性的几种危险因素是众所周知的。对于这些因素中的某些因素,生物学基础可能很普遍,主要表现为内侧颞叶硬化或局灶性病变的存在。在其他情况下,微发育不全或发育异常的皮层,以及局部回路(抑制性)神经元的形态和分布异常,可能是癫痫发作的严重程度的原因。基因在调节不足的实质内药物浓度中的可能影响,以及某些细胞因子决定细胞内钙水平升高或营养神经突过度生长的作用,构成了其他可能的耐药机制。关于DRE产生的机制的一些假设已被指出:(a)脑成熟中的个体异常; (b)癫痫诱发的易发作区域(如海马体)的网络,神经元和神经胶质特性发生改变; (c)点燃现象; (d)响应癫痫发作引起的氧气供应紊乱而重组皮质组织。此类假说需要用专门致力于的顽固性癫痫的适当实验模型加以证实,但迄今为止尚缺乏这种模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号